During the past decade, Mercury Clinical Research conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 12 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 11 clinical trials were completed. i.e. 137.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercury Clinical Research" #1 sponsor was "Pfizer" with 4 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "AEON Biopharma, Inc." with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored and "Jazz Pharmaceuticals" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercury Clinical Research" #1 collaborator was "PPD" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Janssen Biotech, Inc." with 1 trials as a collaborator and "SerenaGroup, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Mercury Clinical Research" are "Influenza" (3 trials), "Diabetic Kidney Disease" (2 trials), "Fibromyalgia" (2 trials), "Migraine" (2 trials) and "Osteoarthritis" (2 trials). Many other conditions were trialed in "Mercury Clinical Research" in a lesser frequency.

Most popular intervention types in "Mercury Clinical Research" are "Drug" (16 trials), "Biological" (4 trials), "Device" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Baloxavir Marboxil" (3 trials), "ABP-450" (2 trials), "Xyrem®" (2 trials) and "Aprocitentan 12.5 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mercury Clinical Research" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Mercury Clinical Research". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 12 completed trials in Mercury Clinical Research, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Mercury Clinical Research, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".